Medical methods for mid-trimester termination of pregnancy (Q24234827)

1

0 references

Marieke I Both

2

0 references

Suzanne Medema

3

0 references

Eeke Thomee

4

0 references

Mark F Wildhagen

5

0 references

Nathalie Kapp

Cochrane Database of Systematic Reviews

6

0 references

publication date

19 January 2011

0 references

published in

0 references

cites work

Randomized controlled trial of misoprostol for second-trimester pregnancy termination associated with fetal malformation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

A randomised study of misoprostol and gemeprost in combination with mifepristone for induction of abortion in the second trimester of pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

A randomized controlled trial comparing two protocols for the use of misoprostol in midtrimester pregnancy termination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

Vaginal versus oral misoprostol for second-trimester pregnancy termination: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

A randomised comparative study on sublingual versus vaginal administration of misoprostol for termination of pregnancy between 13 to 20 weeks

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

A randomized trial to compare two dosing intervals of misoprostol following mifepristone administration in second trimester medical abortion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

A randomized trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion at 13-20 weeks gestation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

A randomised controlled trial of 6 and 12 hourly administration of vaginal misoprostol for second trimester pregnancy termination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

Mifepristone in second-trimester medical abortion: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

Second-trimester pregnancy termination: comparison of three different methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

Randomized comparison of vaginal (200 microg every 3 h) and oral (400 microg every 3 h) misoprostol when combined with mifepristone in termination of second trimester pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

A comparison between two doses of intravaginal misoprostol and gemeprost for induction of second-trimester abortion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

Comparison of extra-amniotic instillation of rivanol and pgf2αeither separately or in combination followed by oxytocin for second trimester abortion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

Randomized comparison of dry tablet insertion versus gel form of vaginal misoprostol for second trimester pregnancy termination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

A prospective, randomized comparison of vaginal misoprostol versus intra-amniotic prostaglandins for midtrimester termination of pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

A prospective randomised comparison of sublingual and vaginal misoprostol in second trimester termination of pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

A prospective randomized comparison of sublingual and oral misoprostol when combined with mifepristone for medical abortion at 12-20 weeks gestation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

A randomised study of two doses of gemeprost in combination with mifepristone for induction of abortion in the second trimester of pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

Comparison of vaginal and sublingual misoprostol for second trimester abortion: randomized controlled equivalence trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

Second-trimester termination with 16,16 dimethyl-PGE1-methyl ester (gemeprost), compared with a regimen that included intra-amniotic PGF2 alpha and hypertonic saline

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

A comparison of two regimens of intravaginal misoprostol for termination of second trimester pregnancy: a randomized comparative trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

The vaginal administration of 9-Deoxo-16,16-dimethyl-9-methylene PGE2 for second trimester abortion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

Sublingual misoprostol 100 microgram versus 200 microgram for second trimester abortion: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

Second-trimester pregnancy termination with 600-microg vs. 400-microg vaginal misoprostol and systematic curettage postexpulsion: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

Efficacy of intravaginal misoprostol in second-trimester pregnancy termination: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

The optimization of intravaginal misoprostol dosing schedules in second-trimester pregnancy termination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

A randomized comparison of two regimens of misoprostol for second-trimester pregnancy termination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

Mifepristone (RU486) and therapeutic late pregnancy termination: a double-blind study of two different doses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

The Relative Value of Two Concentrations of Hypertonic Saline for Midtrimester Abortion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

A randomised trial of oral versus vaginal administration of misoprostol for the purpose of mid-trimester termination of pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

Efficacy of two regimens of misoprostol for early second-trimester pregnancy termination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

Second trimester pregnancy termination: a comparison of 600 and 800 micrograms of intravaginal misoprostol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

Termination of second trimester pregnancy with sulprostone and mifepristone: a randomized double-blind placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

A comparison of intravaginal misoprostol with prostaglandin E2 for termination of second-trimester pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

Mifepristone and misoprostol versus Dilapan and sulprostone for second trimester termination of pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

A randomized comparison of misoprostol to intrauterine instillation of hypertonic saline plus a prostaglandin F2alpha analogue for second-trimester induction termination in Uzbekistan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

Inhibition of progesterone secretion with trilostane for mid-trimester termination of pregnancy: randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

The use of misoprostol for mid-trimester therapeutic termination of pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

Vaginal vs. oral misoprostol for mid-trimester abortion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

Second trimester abortion using intravaginal misoprostol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

High-dose vaginal misoprostol versus concentrated oxytocin plus low-dose vaginal misoprostol for midtrimester labor induction: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

The effect of indomethacin on the instillation-abortion interval in rivanol-induced mid-trimester abortion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

Concentrated oxytocin plus low-dose prostaglandin E2 compared with prostaglandin E2 vaginal suppositories for second-trimester pregnancy termination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

Midtrimester abortion: a comparison of intraamniotic prostaglandin F2alpha and hypertonic saline

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

Vaginal misoprostol versus concentrated oxytocin and vaginal PGE2 for second-trimester labor induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

Prenatal diagnosis and selective abortion: a challenge to practice and policy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

Prenatal diagnosis and abortion for congenital abnormalities: is it ethical to provide one without the other?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

Misoprostol for second trimester pregnancy termination in women with prior caesarean: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

Survey of prenatal screening policies in Europe for structural malformations and chromosome anomalies, and their impact on detection and termination rates for neural tube defects and Down's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

Progesterone receptor blockage. Effect on uterine contractility and early pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

An historical overview of second trimester abortion methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

Medical termination of pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

Risk factors associated with presenting for abortion in the second trimester

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

Manufacturer's warning regarding unapproved uses of misoprostol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

Misoprostol and pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

The continuing need for late abortions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

Mifepristone combined with misoprostol versus intra-amniotic injection of ethacridine lactate for the termination of second trimester pregnancy: a prospective, open-label, randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

Reasons for second trimester abortions in England and Wales

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

Comparison of prenatal ultrasound and postmortem findings in fetuses and infants with central nervous system anomalies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

Comparison of prenatal ultrasound and postmortem findings in fetuses and infants with congenital heart defects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

Pharmacokinetics of different routes of administration of misoprostol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

Misoprostol: pharmacokinetic profiles, effects on the uterus and side-effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

Medical termination of early pregnancy with mifepristone (RU 486) followed by a prostaglandin analogue. Study in 16,369 women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

Off-label use of misoprostol in obstetrics: a cautionary tale

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

Misoprostol and the debate over off-label drug use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

Abortion with sulprostone, a prostaglandin E2 derivative

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

7 January 2021

Correlation between prenatal ultrasound and fetal autopsy findings in fetal anomalies terminated in the second trimester

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

7 January 2021

Correlation between prenatal ultrasound and autopsy findings: A study of second-trimester abortions

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

7 January 2021

Randomized comparison of second trimester pregnancy termination utilizing saline moistened or dry misoprostol

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

7 January 2021

Randomized trial of intracervical prostaglandin E2 gel and intraamniotic prostaglandin F2 alpha for induction of second trimester abortion

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

7 January 2021

A study of gemeprost alone, dilapan or mifepristone in combination with gemeprost for the termination of second trimester pregnancy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

7 January 2021

Termination of second trimester pregnancy with gemeprost and misoprostol: a randomized double-blind placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

7 January 2021

Mid-trimester termination of pregnancy with 16,16-dimethyl-trans-Δ2PGE1vaginal pessaries: A comparison with intra- and extra-amniotic prostaglandin E2administration

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

7 January 2021

Use of prostaglandin, hypertonic saline and oxytocin for second-trimester abortion

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

7 January 2021

Midtrimester abortion by intracervical prostaglandin E2

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

7 January 2021

Second-trimester abortion by intramuscular 15-methyl-prostaglandin F2 alpha or intravaginal prostaglandin E2 suppositories: a randomized trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

7 January 2021

Regio and stereospecific synthesis of 11 beta-substituted 19-norsteroids. Influence of 11 beta-substitution on progesterone receptor affinity - (1)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

7 January 2021

Second trimester pregnancy termination including fetal death: comparison of five different methods

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

7 January 2021

Second-trimester uterine evacuation: A comparison of intra-amniotic (15S)-15-methyl-prostaglandin F2alpha and intravaginal misoprostol

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

7 January 2021

Abortion during mid-pregnancy by rivanol-catheter supplemented with PGF2 alpha drip-infusion or quinine hydrocholoride

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

7 January 2021

Misoprostol is as effective as gemeprost in termination of second trimester pregnancy when combined with mifepristone: a randomised comparative trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

7 January 2021

Vaginal misoprostol compared with vaginal gemeprost in termination of second trimester pregnancy. A randomized trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

7 January 2021

Absorption kinetics of misoprostol with oral or vaginal administration

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

7 January 2021

Vaginal misoprostol compared with oral misoprostol in termination of second-trimester pregnancy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

7 January 2021

Randomized study on the effect of adding oxytocin to ethacridine lactate or misoprostol for second-trimester termination of pregnancy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

7 January 2021

Misoprostol (alone) in second trimester terminations of pregnancy: as effective as Gemeprost?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

7 January 2021

Second-trimester termination of pregnancy by extra-amniotic prostaglandin F2alpha or endocervical misoprostol. A comparative study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

7 January 2021

Induction of abortion in the second trimester by a combination of misoprostol and mifepristone: a randomized comparison between two misoprostol regimens

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

7 January 2021

The effect of RU486 administered during the proliferative and secretory phase of the cycle on the bleeding pattern, hormonal parameters and the endometrium

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

7 January 2021

The abortifacient effect of misoprostol in the second trimester. A randomized comparison with gemeprost in patients pre-treated with mifepristone (RU486)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

7 January 2021

Medical abortion in women of less than or equal to 56 days amenorrhoea: a comparison between gemeprost (a PGE1 analogue) alone and mifepristone and gemeprost

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

7 January 2021

Induction of second trimester abortion with mifepristone and gemeprost

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

7 January 2021

A comparison of 600 and 200 mg mifepristone prior to second trimester abortion with the prostaglandin misoprostol

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

7 January 2021

Mid-trimester abortion by extraamniotic Emcredil versus normal saline

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

7 January 2021

A randomized trial of 2 regimens for the administration of vaginal prostaglandins (gemeprost) for the induction of midtrimester abortion

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

7 January 2021

Comparison of intra-amniotic prostaglandin F2 alpha and hypertonic saline for induction of second-trimester abortion

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

7 January 2021

Comparative study of cervical laminar tents prior to extra-amniotic injection of ethacridine lactate (Rivanol) and a condom-nelathon catheter method for second-trimester pregnancy interruption in Vietnam

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

7 January 2021

Intra-amniotic injection of oxytetracycline hydrochloride for termination of mid-trimester pregnancy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

7 January 2021

Second-trimester abortion by extra-amniotic instillation of Rivanol combined with intravenous administration of oxytocin or prostaglandin F2 alpha

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

7 January 2021

Comparison of ethacridine lactate and prostaglandin E2 in second trimester medical abortion

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005216.PUB2

7 January 2021

10.1002/14651858.CD005216.PUB2

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

21249669

1 reference

Consolidated OpenCitations Corpus – April 2017